Pharmagest Belgium SRL
19.6 FTEPharmagest Belgium reported total assets of €1.14m at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026), with 19.6 full-time equivalents.
By total assets for 2025, Pharmagest Belgium ranks among the 500 largest of the 1,340 companies in its sector (NACE 4650) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharmagest Belgium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +11 % Headcount (avg FTE) -5 %
Accounts of the company itself (not consolidated).
The full file covers 20 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmagest Belgium's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 31 Oct 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Pharmagest Belgium's financial analysis
- Solvency-249.9%sector median: 43.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmagest Belgium
Pharmagest Belgium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.626.524
- VAT number
- BE0476626524
- Peppol
- Registered · 0208:0476626524 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jan 2002
- Registered office
- 6041 Charleroi
- Size
- Small · 19.6 FTE
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Wholesale of information and communication equipment (NACE 46500)
Pharmagest Belgium (SRL) has been based in Charleroi since 2002, active in: wholesale of information and communication equipment. For 2025, it reports a net loss of 86,260 € and equity of −€2.85m; its revenue is not published. With 19.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -249.9%, below the median of its sector (43.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmagest Belgium
Companies in the same business, of comparable size and area, outside its group.
- Cadmes Systems Wholesale of information and communication equipment Merelbeke-Melle · balance sheet €5.54m
- Marchy Wholesale of information and communication equipment Ottignies-Louvain-la-Neuve · balance sheet 303,942 €
- Discoveries Wholesale of information and communication equipment La Roche-en-Ardenne · balance sheet 106,944 €
- Dalux Belgium Wholesale of information and communication equipment Brussels · balance sheet 440,723 €
- Paperbox Wholesale of information and communication equipment Ghent · balance sheet €1.28m
- Braincode Wholesale of information and communication equipment Lessines · balance sheet €1.23m
- Surus Wholesale of information and communication equipment Saint-Gilles · balance sheet 913,452 €
- USW Wholesale of information and communication equipment Ghent · balance sheet 858,317 €
Frequently asked questions about Pharmagest Belgium
What is the revenue of Pharmagest Belgium?
Pharmagest Belgium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmagest Belgium?
In Belgium, the VAT number is the company number prefixed with BE: BE0476626524 for Pharmagest Belgium, if the company is VAT-registered. Its company number (CBE) is 0476.626.524.
Where is the registered office of Pharmagest Belgium?
According to the CBE register, the registered office of Pharmagest Belgium is in 6041 Charleroi.
What is the equity of Pharmagest Belgium?
At the close of the 2025 financial year, the equity of Pharmagest Belgium amounts to -2,848,217 €, a solvency of -249.9% of total assets.
How many people work at Pharmagest Belgium?
19.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmagest Belgium?
The register lists 1 active mandates at Pharmagest Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharmagest Belgium within its sector?
By total assets for 2025, Pharmagest Belgium ranks among the 500 largest of the 1,340 companies in its sector (NACE 4650) in Belgium that filed accounts for that financial year.
The full file of Pharmagest Belgium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →